Cargando…

ER-Negative Breast Cancer Is Highly Responsive to Cholesterol Metabolite Signalling

Interventions that alter cholesterol have differential impacts on hormone receptor positive- and negative-breast cancer risk and prognosis. This implies differential regulation or response to cholesterol within different breast cancer subtypes. We evaluated differences in side-chain hydroxycholester...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hutchinson, Samantha A, Lianto, Priscilia, Roberg-Larsen, Hanne, Battaglia, Sebastiano, Hughes, Thomas A, Thorne, James L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893441/ https://www.ncbi.nlm.nih.gov/pubmed/31683867 http://dx.doi.org/10.3390/nu11112618

Ejemplares similares

Characterization and prognostic value of LXR splice variants in triple-negative breast cancer
por: Lianto, Priscilia, et al.
Publicado: (2021)

Phytosterols Inhibit Side-Chain Oxysterol Mediated Activation of LXR in Breast Cancer Cells
por: Hutchinson, Samantha A., et al.
Publicado: (2019)

Liver x receptor alpha drives chemoresistance in response to side-chain hydroxycholesterols in triple negative breast cancer
por: Hutchinson, Samantha A., et al.
Publicado: (2021)

Signals from the various immune cells in promoting food allergy-induced eosinophilic esophagitis like disease
por: Lianto, Priscilia, et al.
Publicado: (2019)

Inhibitory effects of quail egg on mast cells degranulation by suppressing PAR2-mediated MAPK and NF-kB activation
por: Lianto, Priscilia, et al.
Publicado: (2018)

Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer
por: Simigdala, Nikiana, et al.
Publicado: (2016)

Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
por: Girgert, Rainer, et al.
Publicado: (2019)

Quail egg homogenate alleviates food allergy induced eosinophilic esophagitis like disease through modulating PAR-2 transduction pathway in peanut sensitized mice
por: Lianto, Priscilia, et al.
Publicado: (2018)

Targeting estrogen to kill ER-positive and ER-negative breast cancer
por: Jordan, VC
Publicado: (2005)

The cholesterol metabolite 27-hydroxycholesterol stimulates cell proliferation via ERβ in prostate cancer cells
por: Raza, Shaneabbas, et al.
Publicado: (2017)

ABCA9, an ER cholesterol transporter, inhibits breast cancer cell proliferation via SREBP‐2 signaling
por: Hwang, Hyeon‐Ji, et al.
Publicado: (2023)

Tamoxifen Action in ER-Negative Breast Cancer
por: Manna, Subrata, et al.
Publicado: (2016)

Jab1 is a target of EGFR signaling in ERα-negative breast cancer
por: Wang, Jiaxu, et al.
Publicado: (2008)

A Switch Role of Src in the Biphasic EGF Signaling of ER-Negative Breast Cancer Cells
por: Zhang, XinTian, et al.
Publicado: (2012)

ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer
por: Reese, Jordan M, et al.
Publicado: (2014)

Apoptosis/Necrosis Induction by Ultraviolet, in ER Positive and ER Negative Breast Cancer Cell Lines
por: Shokrollahi Barough, Mahdieh, et al.
Publicado: (2015)

Immunolocalization of Cytoplasmic ER in ER-negative Breast Carcinoma as a Potent Favorable Prognostic Predictor
por: Ebata, Akiko, et al.
Publicado: (2023)

A Role for ER-Beta in the Effects of Low-Density Lipoprotein Cholesterol and 27-Hydroxycholesterol on Breast Cancer Progression: Involvement of the IGF Signalling Pathway?
por: Mashat, Reham M., et al.
Publicado: (2021)

High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer
por: Chin, Suet F, et al.
Publicado: (2007)

Regulation of IMP3 by EGFR Signaling and Repression by ERβ: Implications for Triple Negative Breast Cancer
por: Samanta, Sanjoy, et al.
Publicado: (2012)

Estrogen Receptor-Alpha 36 Mediates Mitogenic Antiestrogen Signaling in ER-Negative Breast Cancer Cells
por: Zhang, XinTian, et al.
Publicado: (2012)

Distinct Genes Related to Drug Response Identified in ER Positive and ER Negative Breast Cancer Cell Lines
por: Shen, Kui, et al.
Publicado: (2012)

Trafficking of cholesterol to the ER is required for NLRP3 inflammasome activation
por: de la Roche, Marianne, et al.
Publicado: (2018)

Targeting the mTOR Pathway for the Prevention of ER-Negative Breast Cancer
por: Mazumdar, Abhijit, et al.
Publicado: (2022)

Protein truncating variants in FANCM and risk for ER-negative/triple negative breast cancer
por: Peterlongo, Paolo, et al.
Publicado: (2021)

Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers
por: Groenendijk, Floris H., et al.
Publicado: (2019)

Metabotropic glutamate receptor 1 is associated with unfavorable prognosis in ER-negative and triple-negative breast cancer
por: Bastiaansen, Anna E. M., et al.
Publicado: (2020)

The ER cholesterol sensor SCAP promotes CARTS biogenesis at ER–Golgi membrane contact sites
por: Wakana, Yuichi, et al.
Publicado: (2020)

BP1 Homeoprotein Enhances Metastatic Potential in ER-negative Breast Cancer
por: Fu, Yebo, et al.
Publicado: (2010)

Andrographolide is an Alternative Treatment to Overcome Resistance in ER-Positive Breast Cancer via Cholesterol Biosynthesis Pathway
por: Rajaratinam, Harishini, et al.
Publicado: (2019)

Bioactive Dietary Supplements Reactivate ER Expression in ER-Negative Breast Cancer Cells by Active Chromatin Modifications
por: Meeran, Syed M., et al.
Publicado: (2012)

Different Proliferation Patterns in Breast Cancer: AgNOR Measurements in ER-Negative and ER-Positive Tumor Cells
por: Günther, Lukas, et al.
Publicado: (2000)

Weight Loss Intervention in Survivors of ER/PR-negative Breast Cancer
por: Vitolins, Mara Z, et al.
Publicado: (2014)

Autoimmune diseases and hypersensitivities improve the prognosis in ER-negative breast cancer
por: Einefors, Rickard, et al.
Publicado: (2013)

Prognostic Impact of HOTAIR Expression is Restricted to ER-Negative Breast Cancers
por: Gökmen-Polar, Yesim, et al.
Publicado: (2015)

High Mutation Burden in ER-Positive/HER2-Negative/Luminal Breast Cancers
por: Voutsadakis, Ioannis A.
Publicado: (2022)

YAP inhibits ERα and ER(+) breast cancer growth by disrupting a TEAD-ERα signaling axis
por: Li, Xu, et al.
Publicado: (2022)

Interfering Role of ERα on Adiponectin Action in Breast Cancer
por: Naimo, Giuseppina Daniela, et al.
Publicado: (2020)

Cholesterol metabolites exported from human brain
por: Iuliano, Luigi, et al.
Publicado: (2015)

Association of TRPS1 gene with different EMT markers in ERα-positive and ERα-negative breast cancer
por: Su, Peng, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_769chd4h3kc1qqd3l0uc59rv3m